These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19917654)

  • 21. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating IGF1 and IGFBP3 in relation to the development of β-cell autoimmunity in young children.
    Peet A; Hämäläinen AM; Kool P; Ilonen J; Knip M; Tillmann V;
    Eur J Endocrinol; 2015 Aug; 173(2):129-37. PubMed ID: 25947142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors.
    Adachi Y; Nojima M; Mori M; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A;
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2104-2111. PubMed ID: 31158304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study.
    Isotton AL; Wender MC; Casagrande A; Rollin G; Czepielewski MA
    Eur J Endocrinol; 2012 Feb; 166(2):207-13. PubMed ID: 22108915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.
    Adachi Y; Nojima M; Mori M; Yamashita K; Yamano HO; Nakase H; Endo T; Wakai K; Sakata K; Tamakoshi A
    World J Gastroenterol; 2017 May; 23(19):3488-3495. PubMed ID: 28596684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.
    Hoyo C; Grubber J; Demark-Wahnefried W; Lobaugh B; Jeffreys AS; Grambow SC; Marks JR; Keku TO; Walther PJ; Schildkraut JM
    J Natl Med Assoc; 2009 Jul; 101(7):711-6. PubMed ID: 19634593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients.
    Meyer NMT; Kabisch S; Dambeck U; Honsek C; Kemper M; Gerbracht C; Arafat AM; Birkenfeld AL; Schwarz PEH; Machann J; Osterhoff MA; Weickert MO; Pfeiffer AFH
    Eur J Endocrinol; 2022 Oct; 187(4):555-565. PubMed ID: 36005859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized GH trial with two different dosages in combination with a GnRH analogue in short small for gestational age children: effects on metabolic profile and serum GH, IGF1, and IGFBP3 levels.
    van der Kaay D; Bakker B; van der Hulst F; Mul D; Mulder J; Schroor E; van Elswijk D; Rowaan I; Willeboer M; de Ridder M; Hokken-Koelega A
    Eur J Endocrinol; 2010 May; 162(5):887-95. PubMed ID: 20176737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum IGF1 with endothelial function: results from the population-based study of health in Pomerania.
    Empen K; Lorbeer R; Völzke H; Robinson DM; Friedrich N; Krebs A; Nauck M; Reffelmann T; Ewert R; Felix SB; Wallaschofski H; Dörr M
    Eur J Endocrinol; 2010 Oct; 163(4):617-23. PubMed ID: 20651065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer.
    Tajtakova M; Pidanicova A; Valansky L; Lachvac L; Nagy V; Sivonova M; Dobrota D; Kliment J; Petrovicova J
    Neoplasma; 2010; 57(2):118-22. PubMed ID: 20099974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic.
    Kucera R; Topolcan O; Pecen L; Kinkorova J; Svobodova S; Windrichova J; Fuchsova R
    Clin Chim Acta; 2015 Apr; 444():271-7. PubMed ID: 25744488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF1 and IGFBP3 in acute respiratory distress syndrome.
    Ahasic AM; Zhai R; Su L; Zhao Y; Aronis KN; Thompson BT; Mantzoros CS; Christiani DC
    Eur J Endocrinol; 2012 Jan; 166(1):121-9. PubMed ID: 22004906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for gestational age (SGA).
    Völkl TM; Schwöbel K; Simm D; Beier C; Rohrer TR; Dörr HG
    Growth Horm IGF Res; 2004 Dec; 14(6):455-61. PubMed ID: 15519254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between circulating reproductive hormones and SHBG and prevalent and incident metabolic syndrome in community-dwelling older men: the Concord Health and Ageing in Men Project.
    Hsu B; Cumming RG; Naganathan V; Blyth FM; Le Couteur DG; Seibel MJ; Waite LM; Handelsman DJ
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2686-91. PubMed ID: 25259909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
    ; Key TJ; Appleby PN; Reeves GK; Roddam AW
    Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study.
    Chubb SA; Hyde Z; Almeida OP; Flicker L; Norman PE; Jamrozik K; Hankey GJ; Yeap BB
    Eur J Endocrinol; 2008 Jun; 158(6):785-92. PubMed ID: 18505902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.
    Frystyk J; Schou AJ; Heuck C; Vorum H; Lyngholm M; Flyvbjerg A; Wolthers OD
    Eur J Endocrinol; 2013 Jan; 168(1):1-8. PubMed ID: 23038624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.